|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 3352857 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16775553.7 |
| Date of filing the European patent application | 2016-09-21 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-13 |
| (46) | Date of publication of the claims translation | 2021-02-25 |
| (86) | Number | PCT/EP2016/072464 |
| Date | 2016-09-21 |
| (87) | Number | WO 2017/050846 |
| Date | 2017-03-30 |
| (30) | Number | Date | Country code |
| 15186258 | 2015-09-22 | EP | |
| 16158710 | 2016-03-04 | EP | |
| 16169699 | 2016-05-13 | EP |
| (72) |
VOORTMAN, Gerrit, NL
KOPER, Norbert Peter, NL
|
| (73) |
Byondis B.V.,
Microweg 22, 6545 CM Nijmegen,
NL
|
| (74) |
Valters GENCS,
J. Basanavičiaus g. 26, Vilnius,
LT
|
| (54) | T-DM1 atsparių, vėžiu sergančių pacientų gydymas junginiu SYD985 |
| SYD985 TREATMENT OF T-DM1 REFRACTORY CANCER PATIENTS |
| Payment date | Validity (years) | Amount | |
| 2024-08-27 | 9 | 208.00 EUR |
| 2025-09-21 |